The Sherwin-Williams Company (NYSE: SHW) — The Best House in Coatings, Already Priced for the Recovery It Can’t Yet See

Independent fundamental research. Report date: 2026-06-13. Price reference: ~$317.30 (2026-06-12 close). All figures reconcile to SEC filings (CIK 0000089800), the FY2025 10-K (filed 2026-02-19), the 2026 proxy (filed 2026-03-11), and management transcripts unless noted.

⚡ Author’s Take

This block is the author’s own subjective opinion. It is general information, not investment advice. The analysis that follows takes no position and names no price target.

Verdict: HOLD / great-business-wrong-price. Accumulate on weakness in the ~$255–285 zone (~22–24x normalized adjusted EPS); not a short. Conviction: medium.

Sherwin-Williams is, by the evidence in this report, the best-run business in global coatings and one of the highest-quality industrials in the U.S. market — a controlled-distribution franchise with a real, widening moat, ~16–17% ROIC, a 22.5% Paint Stores margin, 47 straight years of dividend increases, and a management team that plays offense in downturns. None of that is in dispute. The dispute is entirely about price versus where we are in the cycle. At ~$317 the stock trades at ~27x FY2026 adjusted EPS and ~21x EV/EBITDA — a ~60–90% premium to PPG and roughly 2.3x Axalta — for a company whose same-store volume has been flat-to-negative for four straight years, whose recent earnings growth was a one-time raw-material-deflation margin recovery that is now lapping and reversing (propylene, ~75% of the basket, is guided up ~50% into a Middle East supply shock), and whose own FY2026 guidance implies just +2.4% adjusted EPS with a volume decline. The market is paying a mid-cycle-compounder multiple for a flat-volume, peak-margin cyclical, underwriting a housing normalization that management itself says it does not see in 2026.

The framing is quality-compounder-at-the-wrong-entry-point, not value and not short. SHW has de-rated honestly from its absurd COVID peak (FY2021: ~50x earnings, 32x EBITDA) back to the middle of its own ten-year band (composite valuation in the 48th percentile of its own history) — so this is not a bubble, it is simply full. The skew on a 12-month view is asymmetric to the downside: the bear case needs only “more of the same” (housing stays frozen, raws bite margins), while the base and bull cases need a turn that is perpetually one year away. On a 3–5 year view the quality wins and the share-gain algorithm compounds through the cycle — which is exactly why I would rather own this on a housing scare in the $255–285 range than chase it here. The single fact that flips me bullish: PSG same-store volume inflects clearly positive (a real existing-home-sales recovery, 30-yr mortgage durably below ~6%). The single fact that flips me bearish: gross margin rolls back toward the low-40s on the propylene cycle while volume stays negative — the “margin recovery was the whole story, and it’s over” scenario. Catchy version: the best house on the block, still priced as if the neighborhood already recovered.

1. Executive Summary

The Sherwin-Williams Company is the global leader in paints and coatings and the dominant force in North American architectural paint, with FY2025 net sales of $23.57B, GAAP diluted EPS of $10.26 (adjusted $11.43), ~16–17% return on invested capital, and ~$3.45B of free cash flow. Its competitive advantage is genuine and unusually legible: it owns the end-to-end chain — formulating and manufacturing its own paint, moving ~95% of volume on its own truck fleet, and selling through ~4,850 company-operated stores that are the exclusive outlets for the Sherwin-Williams brand and account for roughly one-third of all specialty paint stores in North America. This controlled-distribution model gives it a structural cost-and-service advantage over dealer- and big-box-distributed rivals (PPG, AkzoNobel, Behr/Masco, Benjamin Moore), the ability to pass raw-material inflation through to customers immediately, and deep switching-cost relationships with professional contractors (including 18 of the top 20 U.S. homebuilders). The financial fingerprint of that moat is a ~5–6 point ROIC premium over PPG and RPM that has endured for years.

The tension is valuation against cycle position. Revenue has been essentially flat from 2022 to 2025 (~2%/yr, almost all price), and FY2025’s reported EPS actually declined 2.7%. The handsome EPS compounding of the last few years (≈15%/yr 2018–2025) was driven overwhelmingly by margin recovery — gross margin rebuilt from 42.1% in 2022 to 48.8% in 2025 as titanium-dioxide and propylene costs deflated while Sherwin held price — plus steady buybacks, not by volume, which has been flat-to-negative across the core for four years. That margin tailwind is now lapping and beginning to reverse: management raised its FY2026 raw-material outlook to “up low-to-mid single digit” on a Middle East energy shock, and its own FY2026 guidance implies adjusted EPS of just $11.50–$11.90 (+2.4% at the midpoint) on a low-single-digit volume decline.

At ~$317 (P/E ~30.5x GAAP / ~27.1x FY2026 adjusted; EV/EBITDA ~20.8x; FCF yield ~4.3%), the market is underwriting a return to high-single/low-double-digit EPS growth that requires a housing and repaint-volume normalization SHW does not yet see. Importantly, the multiple is not at a record — SHW has de-rated from its 2021 peak to the middle of its own 10-year range (48th percentile composite) — but it remains a large premium to coatings peers and to its own pre-Valspar (pre-2017) norms, with no compression despite growth decelerating to ~2%. This is a wide-moat compounder trading at a full-to-rich price; the business quality is not the question, the entry point is. The analysis below takes no position; the valuation discussion is framed strictly as embedded expectations and scenarios.

2. Business Overview

Sherwin-Williams, founded in Cleveland in 1866, develops, manufactures, distributes, and sells paint, coatings, and related products to professional, industrial, commercial, and retail customers. It reports three segments (FY2025 external net sales of $23,574.3M; consolidated pretax income $3,338.2M, 14.2% margin):

A structural feature that the segment optics obscure: CBG manufactures most of what PSG sells. Roughly 63% of CBG’s output (~$5.39B) is intersegment, shipped to PSG stores. So PSG plus CBG-internal — about 71% of the enterprise — is really a single North American architectural paint franchise, and the bulk of Sherwin’s profit pool sits there. PSG operates the controlled-distribution model: 4,853 company-operated stores (only ~206 of which are owned; the rest leased), +80 net openings in 2025, serving primarily professional architectural contractors backed by trained store managers and field reps, plus targeted DIY customers. CBG sells a premier branded portfolio (Valspar, Minwax, Cabot, Krylon, Dutch Boy, HGTV Home by Sherwin-Williams, Thompson’s WaterSeal, and the newly acquired Suvinil/Glasu! in Brazil) through third-party retailers and distributors in North America and Europe, runs 307 company-operated stores in Latin America, and houses the company’s global procurement/manufacturing/distribution. PCG sells high-performance industrial coatings (Macropoxy, Firetex, ValPure, automotive refinish, packaging/coil, protective & marine) into more than 120 countries.

The business model is built on recurring, consumable demand: paint is a maintenance-and-repaint product as much as a new-construction product, and the professional-contractor customer buys repeatedly, in volume, on credit, with technical support and just-in-time delivery. Roughly 80% of revenue is North American/in-region, and foreign operations (~20% of sales) generate only ~10% of pretax profit — Sherwin’s economics are overwhelmingly a North American story. The company employs ~64,200 people, was added to the Dow Jones Industrial Average in November 2024, and is led by CEO Heidi Petz (since January 2024) and CFO Benjamin Meisenzahl (since January 2026).

The store economics are the heart of why PSG earns a 22.5% segment margin while a dealer- or shelf-distributed competitor cannot. A mature Sherwin store is a small-footprint, low-capital outlet (most are leased; only ~206 of 4,853 are owned) staffed by a handful of people, carrying inventory that turns quickly against local Pro demand. The incremental store is cheap to open and reaches profitability fast, which is why Sherwin can open ~80–100 net stores a year through a downturn: each new store cannibalizes little, densifies the network (shortening delivery routes and wait times for contractors), and compounds the service advantage. Because the store is both the distribution point and the customer-relationship node — order-taking, color-matching, credit, technical advice, job-site delivery scheduling — Sherwin captures the full manufacturing-plus-distribution-plus-retail margin that competitors split with independent dealers or surrender to big-box buyers. This is the mechanism that turns “we own our stores” from a slogan into a 5–6 point ROIC premium.

A look at the segment trend sharpens the picture. PSG external sales grew from ~$11.6B (2022) to $13.6B (2025) — solid, but increasingly price-led as same-store volume flattened. PCG has been the laggard, with industrial/auto/packaging end-markets stuck in a multi-year soft patch (FY2025 segment sales ~$6.8B, roughly flat), and its 13.9% GAAP margin (17.3% adjusted) sits well below PSG because it lacks the store-network advantage and competes head-to-head with PPG and Axalta. CBG (~$3.2B) is the most volatile and lowest-quality revenue line — heavily DIY/private-label and big-box-dependent — and its FY2025 growth was essentially all the acquired Suvinil business; its reported margin (16.1% GAAP / 19.3% adjusted) flatters the external business because the segment also books the profit on the supply chain that feeds PSG.

Verdict: A high-quality, cash-generative, consumable-demand business with a concentrated and extremely profitable North American architectural core (PSG at 22.5% margins) and two supporting segments of lower but respectable profitability. Revenue is more cyclical than the “consumer staple” reputation suggests — it tracks housing turnover, repaint activity, and industrial production — but the repaint/maintenance base provides a meaningful floor.

3. Industry Dynamics

The global paints and coatings industry was ~$188.8B in 2024 (North America ~$41.7B), growing roughly 4–5%/yr long-term — a mature, GDP-plus market. Over two decades it has consolidated from a fragmented field into a global oligopoly: Sherwin-Williams is #1 worldwide (~$23.6B), ahead of PPG Industries (~$18.3B), AkzoNobel (~$12.0B), Nippon Paint, RPM International (~$8.1B), and Axalta (~$5.3B). The economics are most attractive in North American architectural paint, where Sherwin’s dominance is near-absolute: ~70% of the market when combining its professional channel and consumer brands, with PSG alone at ~60% of NA architectural volumes — roughly 4x Behr (Masco) and 7x PPG’s NA architectural business. The top four players control ~90% of U.S. architectural volume.

The persistent gap between Sherwin’s ~16–17.5% ROIC and PPG’s ~11% / RPM’s ~13% is one of the most important quantitative facts about this industry: the profit pool is not evenly shared among the oligopolists. Sherwin’s controlled-distribution model captures a structurally higher return on the same commoditized inputs, and that gap has not closed.

Three structural barriers protect the incumbents and explain the consolidation:

1. Low value-to-weight ratio. Liquid paint is heavy and cheap per pound; it cannot be economically shipped across oceans or continents. Competing requires a dense, local network of manufacturing plants and distribution/retail points in-region. A low-cost Asian manufacturer cannot import its way into the U.S. architectural market — it must build domestic plants, secure environmental permits, and establish physical retail access. This is the single most important fact about the industry and the foundation of Sherwin’s moat.
2. Commoditized, volatile inputs → scale-procurement leverage. The key inputs are titanium dioxide (TiO2, for opacity/whiteness) and petrochemical derivatives (propylene-based resins, solvents). These are commodities with violent price cycles; only large players secure favorable contract terms and absorb/pass through swings effectively.
3. Regulation as a moat-deepener. California’s CARB and the U.S. EPA continuously ratchet down permissible VOC limits, forcing reformulation. In 2024 California lowered the interior-flat VOC ceiling to 50 g/L, forcing reformulation of ~40% of products sold in-state. Only apex players with large R&D budgets can keep reformulating compliant, high-performance coatings — raising costs for, or eliminating, smaller competitors.

The raw-material mechanics deserve emphasis because they drive the entire recent earnings narrative. Sherwin’s input basket is dominated by petrochemical derivatives — propylene-based resins and solvents are ~75% of the basket — with titanium dioxide the other major pigment input. These costs are violently cyclical: they spiked in 2021–2022 (crushing gross margin to 42.1%), then deflated through 2023–2025 (rebuilding it to 48.8%). The crucial asymmetry is that Sherwin, distributing through its own stores, raises price immediately when costs rise and is slow to give it back when costs fall — so a deflationary input window translates into a multi-year margin tailwind. That is exactly what happened: the bulk of the 2023–2025 EPS growth was this margin recovery, not volume. The corollary, central to the current thesis, is that the window has closed and is reversing — management’s FY2026 raw-material outlook moved to “up low-to-mid single digit,” with propylene guided up ~50% on Middle East energy risk — so the tailwind that flattered recent earnings becomes a headwind, partly offset by the January 2026 price increase.

The most important secular force has been the DIY-to-Professional (DIFM) shift. In 1980, ~60% of U.S. paint volume was sold to DIY consumers; by 2023, professional contractors (“Do-It-For-Me”) accounted for ~63% of volume. This matters enormously for pricing power: for a professional, paint is ~20% of a job’s cost and labor is ~80%, so the contractor is price-inelastic on paint and intensely sensitive to availability, color-match reliability, and on-time delivery — exactly what Sherwin’s controlled network provides. The DIY consumer, by contrast, is price-sensitive and promotion-driven, which is why the DIY-heavy channel (big box, CBG-external) is structurally lower-margin and more contested.

A Marathon capital-cycle read is favorable to the leaders: rather than over-investing at the top of the cycle, the rational supply-side behavior here is Sherwin adding stores counter-cyclically while weaker competitors (PPG has been shrinking its ~1,000-store base; Kelly-Moore exited) retrench — letting the strongest player capture share entering the recovery. Capital is not flooding in; the barriers keep it out.

The capital-cycle lens is unusually clean here because the supply side is consolidating into the downturn rather than expanding. In the classic Marathon framework, high returns attract capital, which competes returns down to the cost of capital — but in NA architectural paint the barriers (local density, regulation, the captive Pro customer) prevent that mean-reversion, and the weak incumbents are exiting capacity (Kelly-Moore’s failure, PPG’s store closures) precisely when demand is depressed. So Sherwin enters the eventual recovery with more relative capacity and fewer competitors — the exact set-up that produced 9–10% growth coming out of 2008–2009. The risk to this read is not new entrants (there are none of scale) but the timing of the demand recovery: counter-cyclical investment only pays if the cycle actually turns, and four years of deferral test that patience.

Verdict: Structurally good — a consolidated oligopoly with high barriers to entry, regulatory tailwinds for scale players, and a price-inelastic professional customer. The caveats are that it is mature (volume grows ~with GDP/housing, not faster) and cyclical (tied to housing turnover and industrial production), so durable alpha for the leader comes from share gains and pricing, not from market growth.

4. Competitive Position

Moat type (Greenwald taxonomy): local/regional economies of scale + customer captivity — the strongest combination, and an unusually durable one. Sherwin’s advantage is not a patent or a brand alone; it is the system. It owns the entire chain end-to-end — it conceives and formulates products, manufactures them in its own plants, moves ~95% of volume on its own ~3,000-vehicle fleet, and sells through its own stores, which are the exclusive outlets for the flagship brand. That vertical, controlled-distribution structure produces several reinforcing advantages that dealer- and big-box-distributed rivals structurally cannot match:

• Density and service in the local market. With ~4,850 stores — roughly one-third of all NA specialty paint stores — a contractor is rarely far from a Sherwin store, can call ahead and have dozens of gallons of a precise hue waiting, or have it delivered to the job site. Competitors distributing through independent dealers or a shelf at Home Depot cannot replicate the same-day, technical-rep-supported service at scale. (One apt comparison is to Fastenal and Old Dominion Freight Line: obsessive, integrated, service-led density in a business where service is the differentiator.)
• Immediate pricing pass-through. Because Sherwin controls its own stores, it can push raw-material inflation through to end customers immediately, whereas PPG and AkzoNobel — distributing more heavily through independent dealers — may lag by months. This is the mechanism that let Sherwin rebuild gross margin so fast in 2023–2025.
• Switching costs and captivity. PRO+ customer credit and loyalty programs, proprietary color-match and tinting history stored for each contractor, JIT delivery integrated into contractors’ workflows, and exclusive national-account relationships (18 of the top 20 U.S. homebuilders/multi-family developers) all raise the cost and friction of switching. Paint is a small, mission-critical input bought repeatedly — the definition of a captive, habitual purchase.
• Culture as a moat. Low single-digit-to-high-single-digit voluntary turnover, ~70% of field leaders promoted from within, and only nine CEOs in 150+ years produce an institutional service consistency that is genuinely hard to copy.

The financial tests confirm the moat. Share-stability test: PASS — Sherwin has gained NA architectural share for decades while PPG shrank and Kelly-Moore failed, the strongest possible signal under Greenwald (a moat shows up as durable or rising share). ROIC test: PASS — Sherwin earns ~16–17.5% ROIC versus PPG ~11% and RPM ~13%; that persistent ~5–6 point premium is the moat’s financial fingerprint, and it has not eroded.

In Greenwald’s framework, the cleanest way to see the moat is the earnings-power-value vs. asset-value gap. A new entrant attempting to replicate Sherwin would have to build hundreds of regional plants, a national fleet, and ~4,850 local stores and then spend years earning the trust of professional contractors who have stored color histories and credit relationships embedded in the incumbent — all to compete for a price-inelastic customer who has no reason to switch. The replication cost vastly exceeds the asset value on Sherwin’s books, and the local-density economies mean a sub-scale entrant earns sub-economic returns long before reaching parity. That is why the share structure is stable-to-improving and the ROIC premium persists: the barrier is not a single patent or brand but the system of local scale plus customer captivity, which is the hardest moat to attack.

Honest limits: the moat is local and segment-specific. It is widest and deepest in PSG (and CBG-internal) — the NA architectural core — where the controlled-distribution density dominates. It is thin-to-absent in CBG-external (DIY/private-label sold through third-party retail, where Sherwin competes on shelf against Behr’s Home Depot exclusivity and is price-taking) and diluted in PCG, where it competes head-to-head with PPG and Axalta on industrial coatings without the store-network advantage (hence PCG’s 13.9% GAAP margin versus PSG’s 22.5%). The enterprise moat is therefore a function of segment mix — and the most valuable 70% of the company is exceptionally well-protected.

Pressure-testing the moat (what could break it?). Intellectual honesty requires asking what would erode this advantage. Four candidate threats, and why each is currently weak: (1) E-commerce / direct-to-contractor — paint’s value-to-weight ratio and just-in-time, color-matched, job-site-delivery requirements make pure e-commerce a poor substitute for the local store; if anything, Sherwin’s own digital tools strengthen the relationship. (2) Big-box encroachment (Home Depot/Behr, Lowe’s) — real in DIY, but big-box has structurally failed to win the professional contractor at scale because it cannot match same-day technical service and credit; the Pro channel is where the profit is. (3) Private label / low-cost entrants — blocked by the local-density and regulatory barriers; sub-scale entrants earn sub-economic returns. (4) Technology / color-matching commoditization — AI color-match could in theory reduce switching costs, but the stored history, credit, and delivery integration are the stickier bonds, not the color science alone. The most realistic erosion path is not a competitor but self-inflicted: over-pricing into a weak market and giving the Pro customer a reason to test alternatives — which is exactly why the January 2026 price increase is the key thing to watch. On balance, the moat is intact and the threats are slow-moving.

Verdict: Durable, and widening in the core. This is a real moat with a clear financial signature, not a narrative. The qualifier is that the protected core is mature and cyclical, so the moat preserves and grows share and margin but does not, by itself, generate fast growth in a flat end-market.

5. Growth History and Forward Opportunities

Sherwin’s long-term record is excellent but must be read in two pieces. Headline revenue grew from ~$11.3B (2015) to $23.57B (2025), but that includes the one-time step-change from the Valspar acquisition (2017, ~$11.3B). Stripping that, the 2018→2025 revenue CAGR is ~4.3%, and 2022→2025 has been essentially flat (~2%/yr) — and almost entirely price, not volume. Diluted EPS, by contrast, compounded from $3.89 (2018) to $10.26 (2025), ~14.9%/yr — but the drivers were margin recovery (gross margin 42.1%→48.8%) and buybacks (diluted share count 285M→250M), not unit growth. FY2025 GAAP EPS actually fell 2.7%.

The volume picture across FY2025 and into 2026 is the crux of the entire thesis:

• PSG: reported growth has been price plus ~1 point of store count; same-store volume has been flat-to-negative for four years. New residential demand “remained very challenging” (management, Q1 2026). The January 1, 2026 list-price increase of 7% (the largest since COVID) is expected to realize only “low single digit” — and management cut its FY2026 volume assumption to a low-single-digit decline.
• PCG: Q1 2026 volume rose low-single-digit but price-mix was flat; the growth came from new accounts (auto refinish, non-BPA packaging conversion), not from a market recovery — core end markets are “still declining.”
• CBG: ex-Suvinil growth is low-single-digit; North American DIY is structurally weak (down low-single-digit). The 2025 CBG sales increase was essentially all Suvinil.

So Sherwin enters 2026 with negative organic volume across most of the company, holding EPS guidance flat (+2.4%) by leaning on price and acquired Suvinil revenue. The decomposition is worth making explicit, because the headline “15 consecutive years of sales increases” masks what is actually happening underneath:

In other words, all four levers except the most important one — unit volume — are working. The company is a superbly run machine idling because its end-market has been in a multi-year freeze. That is the bull’s opportunity (operating leverage is dormant, not destroyed) and the bear’s warning (you are paying a growth multiple for something currently not growing in units).

The forward opportunity set is real but mostly optionality on a cyclical turn:

1. Latent repaint volume. Existing-home turnover sits near multi-decade lows; the deferred repaint and remodel activity is pent-up, not destroyed. When mortgage rates ease and housing turnover normalizes, the repaint cycle should release — and Sherwin, having added stores counter-cyclically, is positioned to capture outsized share (it did exactly this coming out of 2008–2009, posting 9–10% growth for several years).
2. Continued Pro share gains. Sherwin has grown ~1.5–2x the market for years; PPG’s retrenchment and Kelly-Moore’s exit hand it share.
3. Operating leverage. Management cites 25–30% incremental margins; a volume recovery would drop through to EPS powerfully.
4. Store productivity + new stores toward a 5,000+ U.S. footprint, plus disciplined M&A (Suvinil in Brazil; fragmented PCG tuck-ins).

The ceiling: the NA architectural core is near antitrust limits (top-4 ≈ 90% of U.S. volume), so incremental capital must increasingly go to lower-return PCG and international, which dilutes the blended return on reinvestment.

Verdict: High-quality growth algorithm, currently stalled on volume. The compounding engine — share gains, pricing, store density, buybacks — is intact and best-in-class, but it is running on price and capital returns while volume waits on a housing recovery that has been deferred for four years. The quality of the model is high; the quality of current growth is low (price/M&A masking negative organic volume).

6. Financial Quality

Sherwin’s financial quality is high on every axis that matters, with two honest asterisks (a buyback-hollowed balance sheet and a recently peaked margin). The eight-year record below shows the shape of the story — a Valspar-driven revenue step-up, a margin trough-and-recovery, relentless share-count reduction, and EPS compounding that outran revenue:

Two facts jump out: revenue has been essentially flat 2022→2025 while EPS rose from $7.72 to $10.26, and the gross-margin line (42.1%→48.8%) explains almost all of that gap. This is the empirical backbone of the “margin recovery, not volume” thesis.

Margins and returns. Gross margin recovered from a 42.1% trough in 2022 (TiO2/propylene spike) to 48.8% in 2025; operating margin from 13.5% to 16.1%; EBITDA margin ~19%. ROIC of ~16–17.5% (2023–2025) sits far above any reasonable cost of capital and well above peers — the clearest quantitative proof of the moat. ROE is optically enormous (42–118%) but is a buyback artifact: years of repurchases have shrunk book equity to ~$4.6B, so ROE and P/B (~17.8x) are not meaningful here and should be ignored in favor of ROIC and FCF metrics. Tangible book is negative (goodwill + intangibles ~$20B, largely from Valspar 2017 and now Suvinil 2025, exceed total equity) — again a consequence of acquisitive, buyback-heavy capital structure, not distress.

Cash generation. Operating cash flow was $3.45B in 2025 (FCF ~$3.45B after ~$798M capex); cash conversion (CFO/NI) ran ~1.2–1.3x, confirming earnings are backed by cash. FCF per share ~$13.9 supports a ~4.3% FCF yield at the current price.

Balance sheet. Net debt was $10.66B at year-end 2025 (ex-leases; ~$12.7B including capital leases), or ~2.4x EBITDA — squarely within the company’s stated 2.0–2.5x target. EBITDA/interest coverage is ~9.6x. The balance sheet is investment-grade and comfortably serviceable, though it is run toward the top of the leverage band, leaving less dry powder than a more conservatively financed peer.

Quality-of-earnings flags (modest). GAAP diluted EPS of $10.26 reconciles to management’s “adjusted” $11.43 via +$0.78 of acquisition-intangible amortization (mostly Valspar; a permanent non-cash GAAP drag that will rise with Suvinil), +$0.34 of severance/restructuring (2025), and +$0.05 of trademark impairment (2025). The amortization add-back is defensible (non-cash, acquisition-driven); the restructuring add-backs are becoming semi-recurring and should be treated with some skepticism — a company that “restructures” every year is arguably reporting an operating cost as a one-time item. SBC is modest (~$124M, ~0.5% of sales). Working capital is well-controlled (cash-conversion cycle ~40 days).

A closer look at the balance sheet. The negative tangible book value (~−$30/share) frightens screens but is economically meaningless here: it is the arithmetic result of paying ~$11B for Valspar (2017) and ~$1.2B for Suvinil (2025) — creating ~$8B of goodwill and ~$12B of other intangibles — while simultaneously retiring ~$11B of equity through buybacks. A business earning 16–17% ROIC on a near-zero tangible-equity base is not fragile; it is capital-efficient (it needs little tangible capital to operate the store model) and acquisitive. The relevant solvency lens is cash-flow coverage, not book equity: ~9.6x EBITDA/interest coverage and ~2.4x net-debt/EBITDA on ~$4.5B of EBITDA and ~$3.4B of FCF is comfortably investment-grade. The honest caveat is that running leverage at the top of the 2.0–2.5x target band while continuing ~$1.7B/yr of buybacks leaves less cushion than a 1.5x-levered peer would have if a deep, prolonged downturn hit — and interest expense is already guided up ~$85M in 2026. Working capital is tightly run (cash-conversion cycle ~40 days; inventory turns reflect the store model), so a downturn would actually release working capital and support FCF — a useful counter-cyclical cushion.

Verdict: Economics clearly improve with scale, and do not deteriorate — but margins are at a cyclical peak. The unit economics, returns, and cash conversion are top-decile for an industrial. The caveat for forward modeling is that 48.8% gross margin reflects a favorable raw-material window that is now closing; a normalized through-cycle margin is likely somewhat lower, which matters when the multiple already capitalizes peak earnings.

7. Capital Allocation

Capital allocation is a clear strength, with two watch items. FY2025 deployed $3.45B of operating cash into ~$1.21B of M&A (Suvinil), $798M of capex, and $2.45B returned to shareholders ($1.66B buybacks + $790M dividends). The five-year deployment pattern is consistent and shareholder-friendly:

The pattern: fund the business and bolt-on M&A first, grow the dividend steadily, and direct the residual to buybacks. Over 2021–2025 Sherwin returned roughly $11–12B to shareholders (~$8.5B buybacks + ~$3.3B dividends) — close to cumulative free cash flow — while still deleveraging and funding Suvinil. The notable wrinkle is 2021’s outsized $2.7B buyback (near the COVID-peak share price) versus the steadier ~$1.4–1.7B since; if anything, Sherwin bought more stock when it was expensive and has not stepped up at the cheaper 2025 levels — the opposite of value-sensitive repurchasing.

M&A — disciplined and infrequent. The two deals that matter are Valspar (2017, ~$11.3B — transformational, well-integrated, the source of the CBG brand portfolio and the recurring amortization) and Suvinil (closed October 1, 2025, $1,211.3M cash for BASF’s Brazilian architectural business, ~$525M of sales → ~2.3x sales). Suvinil is a sensible bolt-on (market leadership in Brazil, the LatAm growth angle) at a reasonable multiple, funded with a 364-day delayed-draw term loan. Sherwin is not a serial over-payer; it makes large deals rarely and tuck-ins opportunistically.

Buybacks — steady but not opportunistic. Sherwin repurchased ~$8.5B of stock over 2021–2025 (~$10.9B over 2020–2025), retiring ~29.5M treasury shares in 2025 alone, with ~29.6M shares remaining authorized (no expiry). Diluted share count fell from 285M (2018) to ~248M. The one critique: repurchases are run as a steady program rather than a value-sensitive one — buyback pace did not surge during the 2025 de-rating, when the stock was cheaper on its own history. A more opportunistic approach would lean in on weakness.

Dividends — elite consistency. Sherwin is a Dividend King with 47 consecutive years of increases; the 2025 dividend was $3.16/share (~30% payout), raised to $0.80/quarter ($3.20/year, ~31% payout) for 2026. The modest payout ratio leaves ample room for continued growth and reinvestment.

Capex and R&D. Capex was $798M in 2025 (down from ~$1.12B in 2024, which carried the new ~$600M Cleveland global HQ — structured as a 30-year lease with ~$1.94B estimated total payments — plus the Brecksville R&D center and Statesville NC distribution). R&D is ~$225M (~1.0% of sales) and SG&A ~32.6% — the latter reflects the labor-and-store-intensive distribution model, which is the cost side of the moat.

Incentive alignment — well-designed. Per the 2026 proxy, the annual cash incentive is driven by consolidated Net Sales, Adjusted EPS, and Adjusted Free Cash Flow (segment leaders add Architectural/Industrial sales, PBT, and RONAE). Long-term PRSUs are weighted 67% Adjusted EPS / 33% Adjusted RONAE over three years — RONAE (return on net assets employed) embeds capital efficiency, which is the right metric for this business. CEO Petz’s 2025 total compensation was ~$14.9M (pay ratio ~248:1); say-on-pay passed at 91.12%. The one yellow flag: the 2023–2025 PRSUs vested at 200% of target (the maximum), which may indicate goals were set conservatively.

Verdict: Management has allocated capital intelligently — disciplined M&A, a fortress dividend, consistent buybacks, capital-efficiency-linked incentives, and a willingness to invest counter-cyclically. The two watch items are (1) buybacks that are steady rather than opportunistic and (2) leverage run at the top of the target band alongside continued repurchases, which trims financial flexibility.

8. Changes and Headwinds — Last Two Years

Leadership transition (orderly). Three C-suite/Chairman changes in two years, all internal succession: Heidi Petz became President & CEO on January 1, 2024 (John Morikis moved to Executive Chairman, then retired effective 12/31/2024); and Allen Mistysyn retired as CFO effective 12/31/2025, with Benjamin E. Meisenzahl (age 44) elected CFO effective January 1, 2026. The depth of the internal bench is itself a quality signal, but a brand-new CEO and a brand-new CFO within 24 months is a transition worth monitoring through a full cycle.

Index inclusion. Sherwin was added to the Dow Jones Industrial Average in November 2024 — a passive-flow and prestige positive, not a fundamental one.

Demand environment — the persistent headwind. For four straight years management has framed results as delivered with “no help from the market”: elevated interest rates, weak new and existing home sales, cautious consumers, and limited industrial spending. New residential construction and existing-home turnover remain depressed; the repaint cycle is deferred. This is the single biggest swing factor and it has not yet turned.

Raw-material cycle inflecting the wrong way. The 2023–2025 deflationary tailwind that rebuilt gross margin is over. On the Q1 2026 call management raised its FY2026 raw-material outlook from “up low” to “up low-to-mid single digit,” citing the Middle East conflict / Strait of Hormuz risk; propylene (~75% of the basket) is forecast up ~50% through 2026. Sherwin claims insulation (~80% in-region sourcing, ~50/50 contract/spot, chloride-route TiO2) and has responded by raising price and trimming volume assumptions — but costs flow to the P&L with a 1–2 quarter lag, weighted to 2H 2026.

Pricing action. The January 1, 2026 PSG list increase of 7% is the largest since COVID — a test of whether Sherwin can hold price into soft volume without ceding share. Management guides only “low single digit” realization on that 7% list number, which tells you two things: discounting/mix erodes much of the headline, and the company is consciously trading some realization for volume retention in a soft market. This is the central near-term execution question — in a controlled-distribution model with a captive Pro customer, Sherwin should be able to hold price; if realization disappoints or Pro customers trade down to PPG/Behr, it would signal the moat is less ironclad than the bulls assume. The spring/summer 2026 selling season is the cleanest read on this we will get.

A forward watch-list for the thesis, in priority order: (1) PSG same-store volume (the master signal — is the freeze thawing?); (2) gross-margin trajectory into 2H 2026 as propylene flows through with a lag; (3) price realization on the January increase; (4) Suvinil integration and the LatAm contribution; (5) any change in buyback cadence at the lower share price. Each is observable quarter-to-quarter, which makes this an unusually trackable thesis.

Verdict: Net neutral-to-slightly-negative for the thesis. The leadership bench and index inclusion are fine; the operating changes — a persistently frozen housing market and a raw-material cycle turning back to inflation just as the margin tailwind laps — pressure the near-term earnings algorithm precisely when the valuation assumes re-acceleration.

9. Risk Analysis (Risk Matrix)

The dominant risks are cyclical and valuation-driven, not existential: a housing recovery that keeps slipping, a raw-material cycle turning against margins, and a premium multiple that capitalizes a re-acceleration not yet visible. The probability of permanent capital impairment is very low; the probability of a disappointing multi-year return from this entry price is materially higher.

10. Valuation Discussion (Embedded Expectations)

No price target and no recommendation. This section frames what the current price implies and lays out scenarios.

At ~$317.30, with ~247.7M shares (~$78.6B market cap) and ~$10.7B net debt (~$89–93B EV), Sherwin trades at:

• P/E ~30.5x GAAP ($10.26) / ~27.8x trailing adjusted ($11.43) / ~27.1x FY2026E adjusted ($11.70 mid)
• EV/EBITDA ~20.8x (FY2025 EBITDA $4.47B)
• EV/EBIT ~24.5x, FCF yield ~4.3%, dividend yield ~1.0%

Versus its own history, the key nuance is that SHW is not at a record multiple. Third-party own-history valuation percentiles (2026-06-12) put P/E in the 36th percentile, P/B 48th, P/S 61st — a 48th-percentile composite, i.e. the middle of its own 10-year band. SHW de-rated honestly from the COVID-era extreme (FY2021: EV/EBITDA ~32x, P/E ~50x) back to normal. So this is “full,” not “bubble.” Versus peers and its own pre-Valspar norms, however, the premium is large and persistent: a ~60–90% EV/EBITDA premium to PPG (~12x) and ~2.3x Axalta (~9x), and ~50–80% above SHW’s own pre-2017 range (~13–22x EV/EBITDA, ~22x P/E) — with no compression despite revenue growth decelerating to ~2%.

The own-history multiple path makes the de-rating concrete:

The stock is roughly half its 2021 multiple but still well above its pre-2017 (pre-Valspar) norm — the question is whether the post-Valspar “premium compounder” multiple is the right anchor or whether mean-reversion toward the low-20s EV/EBITDA continues if growth stays at ~2%.

Embedded-expectations / reverse-DCF read. Working backwards: at ~$317 with ~$3.45B FCF and ~248M shares, the FCF yield is ~4.3%. For an equity investor to earn a ~9–10% total return from here, FCF/EPS must grow ~5–6%/yr and the multiple must hold. Sherwin’s FY2026 guide is +2.4% adjusted EPS, and the multi-year algorithm only reaches high-single/low-double-digit EPS growth if volume normalizes (the dormant 25–30% incremental margins drop through). So the current price embeds an assumption that the volume freeze is temporary and that a housing-led repaint recovery resumes within ~1–2 years — restoring mid-teens EPS growth and validating the premium multiple. Paying ~27x forward adjusted EPS and ~21x EBITDA for a business guiding +2.4% adjusted EPS on declining volume only makes sense if you underwrite a return to high-single/low-double-digit EPS growth within the next 1–2 years — which requires the housing/repaint volume normalization management explicitly does not see in 2026. In other words, the price capitalizes a cyclical turn and the durability of peak margins and the persistence of the premium multiple. That is three things going right, against a backdrop where the bear case requires only “more of the same.”

Scenarios (illustrative; explicit assumptions; not targets):

On a 12-month view the skew is asymmetric to the downside — base and bull both need a turn SHW does not yet see, while the bear needs only continuity. On a 3–5-year view, the quality and the share-gain algorithm tilt the odds back toward the base/bull, which is why the business is a far more attractive proposition on a pullback than at the current full price.

11. Variant Perception

Consensus view: Sherwin is a best-in-class quality compounder whose recent flatness is a cyclical air-pocket; buy the dip and wait for the housing recovery to re-accelerate EPS. Sell-side leans positive (roughly 15 Buy / 10 Hold / 1 Sell, median price target ~$400, ~2026 EPS consensus ~$12), embedding a housing-recovery call.

Strongest bull case: A decade-plus, 1.5–2x-the-market share machine with a controlled-distribution moat that widens as competitors (PPG, Kelly-Moore) stumble; dormant 25–30% incremental operating leverage that will drop through powerfully when volume turns; pristine capital allocation and a 47-year dividend record; and a balance sheet and management built to play offense in downturns. When housing normalizes, EPS re-accelerates to the mid-teens and the premium multiple is justified.

Strongest bear case: You are paying ~27–30x earnings / ~21x EBITDA for a cyclical at peak margins and trough volume growing ~2%. The “compounding” of 2023–2025 was a one-time raw-material-deflation margin recovery — not volume — and that tailwind is now lapping and reversing into a propylene shock. Same-store volume has been flat-to-negative for four years; the easy share grab (Kelly-Moore) is behind it; housing has been “next year” for four years running; and the multiple sits ~50–80% above pre-2017 norms with no compression despite decelerating growth. If the housing turn slips again while margins give back the raw-material gift, both the E and the multiple compress together.

The 3–5 assumptions that decide it:

1. Housing/existing-home-sales timing — when (or whether) repaint volume normalizes.
2. Margin durability vs. propylene — does Sherwin hold ~48% gross margin through the cost cycle, or mean-revert?
3. Multiple persistence — does the premium hold, or compress toward peers/pre-2017 norms?
4. Share-gain sustainability post-Kelly-Moore and post-PPG-retrenchment.
5. Capital-allocation discipline — Suvinil accretion and whether buybacks stay disciplined at ~27x.

Falsification tests: the bull case fails if PSG same-store volume stays flat-to-negative through 2H 2027 while gross margin contracts on raws (i.e., the margin recovery was the whole story and it is over). The bear case fails if volume inflects clearly positive (rates durably <6%, existing-home sales recover) and gross margin holds/expands despite propylene, with EPS re-accelerating to double digits.

12. Fact vs. Interpretation Table

13. Open Questions

1. How durable is price without volume? Can Sherwin realize and hold the 7% January-2026 PSG list increase through soft demand without ceding Pro share? The spring/summer 2026 selling season is the tell.
2. Is the gross-margin gift reversing or just pausing? How much of the 48.8% gross margin survives a propylene cost cycle guided up ~50%? (Watch 2H 2026, when costs flow through with a lag.)
3. When does housing actually turn? Existing-home-sales/mortgage-rate path is the master variable; four years of “next year” have been wrong.
4. Are restructuring add-backs becoming a permanent operating cost dressed up as one-time items? Track the cadence of severance/restructuring adjustments.
5. Does buyback discipline hold at ~27x with leverage at the top of the band, and how much does the Suvinil amortization step-up widen the GAAP-vs-adjusted gap?
6. New CEO + new CFO through a full cycle — does the capital-allocation and pricing discipline persist under Petz/Meisenzahl?

14. What Must Be True (Bull and Bear, with Falsification Tests)

Bull case — what must be true:

• Existing-home turnover and new-residential demand normalize within ~1–2 years, releasing deferred repaint volume; PSG same-store volume inflects positive.
• Gross margin holds near ~48% through the propylene cycle (pricing offsets cost).
• Sherwin keeps gaining Pro share at ~1.5–2x the market; 25–30% incremental margins drive mid-teens EPS growth; the premium multiple persists.
• Falsification: PSG same-store volume stays flat-to-negative through 2H 2027 and gross margin contracts on rising raws — the “margin recovery was the whole story, and it’s over” outcome.

Bear case — what must be true:

• Housing stays frozen; core volume remains flat-to-negative; price increases stick less than hoped or cost share.
• The 2023–2025 margin recovery reverses as propylene/TiO2 inflate, compressing EPS.
• The premium multiple mean-reverts toward peers/pre-2017 norms as growth disappoints, compressing E and the multiple together.
• Falsification: volume inflects clearly positive (rates durably <6%), gross margin holds/expands despite propylene, and EPS re-accelerates to double digits — validating the compounder framing and the premium.

15. Source Appendix

Primary sources: SHW FY2025 Form 10-K (filed 2026-02-19, CIK 0000089800); FY2021–FY2024 10-Ks; 2026 DEF 14A proxy (filed 2026-03-11); Q3 2025, Q4 2025, and Q1 2026 earnings-call transcripts; the full Form 4 insider history (EDGAR, 2016–2026); SHW 2024 and 2025 Annual Reports; third-party financial statements and ratios; third-party own-history valuation percentiles. Qualitative context: public industry data and third-party analysis of the coatings market and Sherwin’s distribution model.

APPENDIX A — Standard Diligence Questionnaire — The Sherwin-Williams Company (NYSE: SHW)

Supplemental to the research memo. Report date 2026-06-13. Fact / Interpretation / Assumption labels applied where material.

General

What thoughtful questions have other investors asked about this company? The recurring institutional debates: (1) How much of the 2023–2025 earnings growth was sustainable operating performance versus a one-time raw-material-deflation margin recovery? (2) Can Sherwin keep raising price into flat-to-negative volume without ceding Pro share? (3) Is the premium multiple (~27x adj EPS, ~60–90% above PPG) justified when organic growth has decelerated to ~2%, and does it compress if housing stays frozen? (4) When does the housing/repaint cycle actually turn — and is Sherwin’s counter-cyclical store build the right way to position for it? (5) Does the moat travel beyond NA architectural into PCG/international, where returns are lower?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Interpretation: a margin high on a volume low. Gross margin (48.8%) and operating margin (16.1%) are near cyclical peaks driven by 2023–2025 raw-material deflation, while unit volume is at a cyclical trough (existing-home sales near multi-decade lows; same-store volume flat-to-negative for four years). This is an unusual combination and it cuts both ways: margins have downside as raws re-inflate, but volume has substantial latent upside on a housing recovery.

Driven by external environment or internal actions? Both. Internal: pricing power, share gains, store openings, mix, cost control. External (currently adverse): interest rates, housing turnover, industrial production, raw-material costs. Management has explicitly delivered “record results with no help from the market” for four years — i.e., internal execution has offset an external headwind.

How stable are revenues? More cyclical than the staple reputation implies, but with a meaningful repaint/maintenance floor (~60%+ of architectural demand is repaint, not new construction). 15 consecutive years of sales increases — but recent increases are price/M&A, not volume.

Outlook for products/services & market size. Global coatings ~$188.8B (2024), ~4–5%/yr; NA architectural ~$41.7B. Fact: mature, GDP-plus market; growth for the leader comes from share and price, not market expansion. Long-term repaint demand is durable; near-term demand is rate-/housing-constrained.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Less at the top — two decades of consolidation into a global oligopoly; PPG shrinking its NA store base, Kelly-Moore exited. Sherwin’s NA architectural position is strengthening.

How profitable is the business (ROIC, ROE)? ROIC ~16–17.5% (the meaningful metric). ROE (42–118%) and P/B (~17.8x) are buyback artifacts of a hollowed book equity (~$4.6B) and should be ignored. PSG segment margin 22.5%.

How profitable is the industry / barriers to entry? Profitable for scale leaders; thin for sub-scale players. Barriers: low value-to-weight ratio (forces local manufacturing/distribution density), commoditized inputs requiring scale-procurement leverage, and CARB/EPA VOC reformulation that favors large R&D budgets. Top-4 ≈ 90% of U.S. architectural volume.

Can the business be easily understood? Yes — make paint, distribute it through your own stores, serve professional contractors better than anyone, hold price.

Can it be undermined by foreign low-cost labor? No. Paint is too heavy/cheap per pound to ship internationally; the controlled domestic network is the moat and cannot be import-arbitraged.

Do brands matter? Yes but secondary to distribution and service. The Sherwin-Williams brand carries Pro trust; Valspar/Krylon/Minwax/Dutch Boy carry DIY shelf presence. The deeper moat is the store network and contractor relationships, not the label.

Nature of competition. Service, availability, technical support, color-match reliability, and immediate pricing — not primarily price-cutting (in the Pro channel). DIY/big-box is more price- and promotion-driven.

Customers’ switching costs. Real in PSG: PRO+ credit, stored color-match/tinting history, JIT job-site delivery integrated into workflows, exclusive national-homebuilder relationships (18 of top 20). Low in CBG-external (DIY).

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The store network’s economic value, contractor relationships, brand, and culture are not capitalized. Conversely, ~$20B of goodwill/intangibles (Valspar, Suvinil) is on the balance sheet, producing negative tangible book.

Off-balance-sheet liabilities? Operating/store leases (most of the ~4,850 stores are leased; capital leases ~$2.1B on-balance-sheet under current accounting); the 30-year Cleveland HQ lease (~$1.94B estimated total payments). Pension is small (~$130M). Historical lead-pigment litigation tail exists but is not currently material.

How conservative is the accounting? Generally clean; cash conversion ~1.2–1.3x NI. Watch item: “adjusted” EPS adds back $0.78 acquisition amortization (defensible, non-cash) plus semi-recurring severance/restructuring ($0.34 in 2025) — the latter is becoming a near-annual “one-time” item and should be viewed skeptically.

How CapEx-hungry? Moderate. Capex ~$798M (2025), ~3.4% of sales, elevated in 2024 by the new HQ/R&D campus. The store model is more SG&A-intensive (labor/leases, ~32.6% of sales) than capex-intensive.

Capital Allocation & Management

How much FCF, and how is it used? ~$3.45B FCF (2025). Priorities: disciplined M&A (Suvinil ~$1.21B), capex, then shareholder returns ($1.66B buybacks + $0.79B dividends). Philosophy: reinvest in the business and stores, bolt-on M&A, grow the dividend, buy back the rest.

Significant acquisitions recently? Suvinil (BASF Brazil architectural, $1,211.3M, ~2.3x sales, closed 10/1/2025). Valspar (2017, ~$11.3B) remains the defining deal.

Buying back shares? Yes — ~$8.5B over 2021–2025; share count 285M (2018) → ~248M. Critique: steady, not opportunistic (no surge during the 2025 de-rating).

Issuing shares to insiders? Modest. SBC ~$124M (~0.5% of sales); PRSU/option grants routine.

Compensation policy. STI: Net Sales + Adjusted EPS + Adjusted FCF (segment heads add sales/PBT/RONAE). LTI PRSUs: 67% Adjusted EPS / 33% Adjusted RONAE over 3 years — capital-efficiency-linked, well-designed. CEO 2025 comp ~$14.9M; say-on-pay 91.12%. Yellow flag: 2023–2025 PRSUs vested at 200% of target (max).

Motivations of management? Largely aligned with per-share value and capital efficiency. Caveat: insiders own <1% of shares and there have been only 8 open-market (code-P) buys in a decade — none since October 2023, and none ever by current CEO Petz. Low personal-ownership conviction signal, though comp design partly offsets.

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — ordinary U.S. common stock, NYSE-listed, files 10-K/10-Q, issues a 1099. Added to the DJIA in November 2024.

Dividend policy? Dividend King — 47 consecutive years of increases; ~$3.20/year for 2026 (~1.0% yield, ~31% payout). Ample room to keep growing.

How profitable? Highly — ~16–17.5% ROIC, 48.8% gross margin, 16.1% operating margin, ~10.9% net margin.

Is net income diverging from cash from operations? No — CFO/NI ~1.2–1.3x; earnings are well-backed by cash.

Risks & Downside

What would cause the stock to decline? A housing recovery that slips further while raws re-inflate (E down); and/or multiple compression toward peers/pre-2017 norms as ~2% growth persists at a ~27x multiple (multiple down). The danger is both happening together.

Risk of catastrophic loss? Very low — investment-grade, ~$3.4B FCF, consumable demand, dominant share. No plausible path to permanent franchise impairment.

Chance of total loss? Negligible.

Recent News & Events

Has the business environment changed recently? Yes, adversely on two fronts: (1) the raw-material cycle inflected from deflation to inflation (propylene guided +~50% on Middle East energy risk, FY26 raws “up low-to-mid SD”); (2) demand stayed weak for a fourth year. (Curated news flow on SHW has been quiet — routine for a large, clean filer — so the event read is built from filings and transcripts.)

Significant acquisitions / accounting changes? Suvinil (10/1/2025); no accounting-policy changes of note. Amortization step-up from Suvinil will widen the GAAP-vs-adjusted EPS gap.

Recent management/structural changes? New CEO (Petz, Jan 2024), new Executive Chairman transition (Morikis retired 12/31/2024), and new CFO (Meisenzahl, Jan 2026); 7% PSG list-price increase effective Jan 1, 2026; continued counter-cyclical store openings (+80 net in 2025).

APPENDIX B — Source Appendix — The Sherwin-Williams Company (NYSE: SHW)

Report date 2026-06-13. Primary sources first. All financial figures reconciled to SEC filings where possible.

Primary — SEC filings (CIK 0000089800)

1. Form 10-K, FY2025 — filed 2026-02-19 (shw-20251231.htm). Segment net sales & profit, store counts, raw materials, competition, MD&A, Suvinil disclosure, GAAP-vs-adjusted reconciliation. Accessed 2026-06-13.
2. Form 10-K, FY2021–FY2024 — filed 2022-02-17, 2023-02-22, 2024-02-20, 2025-02-20. Multi-year segment/margin trends, Valspar amortization.
3. DEF 14A proxy — filed 2026-03-11 (shw-20260310.htm). Executive compensation metrics (STI: Net Sales/Adj EPS/Adj FCF; LTI PRSU 67% Adj EPS / 33% Adj RONAE), CEO pay (~$14.9M), say-on-pay (91.12%), beneficial ownership (insiders <1%). Plus 2022–2025 proxies.
4. Form 8-K corpus (63 filings, 2024–2026) — CEO transition (Petz, eff 1/1/2024; Morikis retirement 11/13/2024), CFO transition (Mistysyn retire 12/31/2025; Meisenzahl elected eff 1/1/2026, dated 11/3/2025), Suvinil DDTL (8/8/2025) and close (10/1/2025), 2025 Equity Plan (4/16/2025), buyback authorizations, quarterly earnings releases.
5. Form 4 insider history (full, 2016–2026, via EDGAR) — code distribution A 368 / M 168 / S 184 / F 139 / G 43 / P (open-market buy) 8 / D 1. Only 8 code-P buys in a decade, none since Oct 2023; CEO Petz no open-market buys.

Primary — Management transcripts (company investor relations)

6. Q1 2026 earnings call (company IR) — 2026-04-28. FY2026 guidance reaffirmed; raw-material outlook raised (“up low-to-mid SD,” propylene +~50%); PSG 7% Jan list increase; volume guided to low-SD decline; new residential “very challenging.”
7. Q4 2025 earnings call (company IR) — 2026-01-29. FY2026 guidance set: GAAP dil EPS $10.70–$11.10; adjusted $11.50–$11.90; segment outlook.
8. Q3 2025 earnings call (company IR) — 2025-10-28. Demand/pricing/Suvinil commentary.

Primary — Annual reports

9. SHW 2025 Annual Report (shw_2025annualreport) — net sales +2.1% to $23.6B (15th consecutive increase); gross margin +30bps to 48.8%; GAAP dil EPS $10.26 (−2.7%); adjusted $11.43 (+0.9%); segment mix PSG 58% / PCG 29% / CBG 13%; ~4,853 stores; ~64,000 employees.
10. SHW 2024 Annual Report — net sales record $23.1B; gross margin +180bps to 48.5%; 14th consecutive sales increase.

Quantitative data services

11. Third-party financial-data aggregators — income statement, balance sheet, cash flow, profitability/credit/liquidity/per-share ratios, enterprise value, valuation multiples (8–11 years). ROIC ~16–17.5%; EV/EBITDA history; net debt ~$10.7B. Reconciled to filings; SEC filings remain primary. Accessed 2026-06-13.
12. Own-history valuation percentiles (third-party) — 2026-06-12: P/E 36th pctile, P/B 48th, P/S 61st, composite 48th; price $317.30.

Industry & peer context

13. Global coatings market structure — global ~$188.8B (2024), NA ~$41.7B; competitor revenue ranks (SHW ~$23.6B > PPG ~$18.3B > AkzoNobel ~$12.0B > Nippon > RPM ~$8.1B > Axalta ~$5.3B). Industry rankings cross-checked against public peer filings (PPG, AkzoNobel, RPM, Axalta annual reports).
14. DIY→Pro/DIFM shift, CARB VOC regulation, NA share estimates (SHW ~70% NA architectural; PSG ~60% NA arch volume). Treat share figures as estimates derived from industry data, not SHW disclosure.

Industry & qualitative references (public)

15. Public industry/market-structure data on the global and North American coatings market (market size, competitor revenue ranks, DIY-to-Pro channel shift, CARB/EPA VOC regulation).
16. Third-party analysis of Sherwin-Williams’ controlled-distribution model (store network, own-fleet delivery, immediate raw-material pass-through vs. dealer-distributed rivals, national-homebuilder relationships).
17. Peer reference: RPM International and PPG public filings for coatings segment structure and end-market cyclicality.